| CTRI Number |
CTRI/2024/12/078482 [Registered on: 23/12/2024] Trial Registered Prospectively |
| Last Modified On: |
24/09/2025 |
| Post Graduate Thesis |
No |
| Type of Trial |
PMS |
|
Type of Study
|
Medical Device |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Follow up study on safety and performance of distal humerus plate system |
|
Scientific Title of Study
|
A Prospective, Single Arm, Post Market Clinical Follow-up (PMCF) Study to Evaluate the
Safety and Performance of Distal Humerus Plate System Intended for Fracture Fixation |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| CR_PMCF/P_28 |
Protocol Number |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Dinesh Chandra |
| Designation |
Director & Consultant |
| Affiliation |
Meerut Orthopaedics & Research Centre |
| Address |
Room No. 5,
Department of Orthopedics
R-120 (opp-water tank), Pallavpuram, Phase-ll, Meerut
Meerut UTTAR PRADESH 250110 India |
| Phone |
7419660141 |
| Fax |
|
| Email |
drdineshchandra2024@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Mohd Aslam |
| Designation |
Clinical Research Manager |
| Affiliation |
Auxein Medical Private Limited |
| Address |
Room No. 2,
Department of Clinical Research
Plot Number 168 â€169â€170, Phase IV, HSIIDC, Industrial Estate Kundli
Sonipat HARYANA 131028 India |
| Phone |
7419660141 |
| Fax |
|
| Email |
clinical2@auxeinmedical.com |
|
Details of Contact Person Public Query
|
| Name |
Mr Gaurav Luthra |
| Designation |
Technical Director |
| Affiliation |
Auxein Medical Private Limited |
| Address |
Room No. 1
Department of Clinical Research
Plot Number 168 â€169â€170, Phase IV, HSIIDC, Industrial Estate Kundli
Sonipat HARYANA 131028 India |
| Phone |
7419660141 |
| Fax |
|
| Email |
gaurav@auxeinmedical.com |
|
|
Source of Monetary or Material Support
|
| Auxein Medical Private Limited. Plot Number 168 â€169â€170
Phase IV, HSIIDC, Industrial Estate Kundli, Sonipat-131028
Haryana, India |
|
|
Primary Sponsor
|
| Name |
Auxein Medical Private Limited |
| Address |
Plot Number 168 â€169â€170
Phase IV, HSIIDC, Industrial Estate Kundli, Sonipat-131028
Haryana, India |
| Type of Sponsor |
Other [Medical device manufacturer] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Dinesh Cahndra |
Meerut Orthopaedics & Research Centre |
Room No. 5
Department of Orthopedics
R-120 (opp-water tank), Pallavpuram, Phase-ll, Meerut-250110 Meerut UTTAR PRADESH |
8630267471
drdineshchandra2024@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Valentis Cancer Hospital Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: S424||Fracture of lower end of humerus, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Distal humerus plate system |
Intervention is intended to provide fixation of distal humerus fracture. The enrolled patients will be followed up at various time points till one year of surgery. |
| Comparator Agent |
Not applicable |
Not applicable |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
75.00 Year(s) |
| Gender |
Both |
| Details |
Patients presenting to Orthopaedic emergency/OPD with distal humerus fractures/ intercondylar humerus fracture. |
|
| ExclusionCriteria |
| Details |
1. Infection, local or systemic, acute or chronic inflammation at the
operative site.
2. Patient with known history of metal allergy.
3. Mental illness or schizophrenic, which may cause patients to
ignore the limitations and precautions of the implanted material
leading to implants fracture and complication.
4. Patients having inadequate tissue coverage over the operative
site.
5. Presence of marked or rapid bone absorption, metabolic bone
disease, cancer, or any other tumorâ€like condition of the bone
which may compromise fixation.
6. Female participant who is pregnant or planning pregnancy during
the course of the study.
7. Chronic alcoholics, and smokers.
8. Any condition or anatomy that makes treatment with the distal
humerus plate system infeasible.
9. Patients who are incarcerated or have pending incarceration. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
1. Evaluation of function outcome scores (MEPS and Quick DASH).
2. Improvement in pain score (VAS). |
Three time points; 3, 6, and 12 months. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Radiological evaluation by X-ray radiographs to assess the mean time taken to achieve bone union.
2. Evaluation of any complications/adverse events associated with
implants. |
Three time points; 3, 6, and 12 months. |
|
|
Target Sample Size
|
Total Sample Size="20" Sample Size from India="20"
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="20" |
|
Phase of Trial
|
Post Marketing Surveillance |
|
Date of First Enrollment (India)
|
25/12/2024 |
| Date of Study Completion (India) |
Date Missing |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The proposed Post marketing clinical follow up study aims to assess the safety and performance of distal humerus plate system being manufactured by Auxein Medical Private Limited. A total of twenty patients of both gender with distal humerus fracture will be enrolled in the study, and will be followed up till one year post-operatively. The study includes assessment of functional outcome, pain scores, radiological evaluation of bone union, and recording and assessment of device associated adverse events. |